Breaking News

Tweet TWEET

Solazyme Loan for Brazil Plant Cuts Borrowing Cost

Solazyme Inc. (SZYM), a U.S. biofuel company, lowered its borrowing costs with a 245.7 million-real ($120 million) loan from Brazil’s national development agency BNDES for a plant it’s building in the South American country.

The funding “represents a sharp reduction in the cost of capital compared to typical clean-technology financings,” Laurence Alexander, an analyst with Jefferies Group Inc. in New York, said in a research note today. It’s “a significant milestone for both Solazyme and the biochemicals industry.”

Solazyme Bunge Renewable Oils, a joint venture with Bunge Ltd. (BG), is paying about 4 percent interest for the eight-year loan, South San Francisco, California-based Solazyme said in a statement yesterday.

Alexander rates Solazyme a buy, with a 12-month price target of $23. Shares fell 9.2 percent to $6.88 at the close in New York.

Solazyme makes oils from sugar-consuming algae that are processed into fuel and specialty chemicals.

The companies broke ground in June on the commercial-scale plant, which is expected to be begin production in the fourth quarter. The facility is adjacent to Bunge’s Moema sugar-cane mill in Sao Paulo state.

The funding is part of a joint program between the development agency, formally Banco Nacional de Desenvolvimento Economico e Social, and the country’s research-financing agency FINEP to encourage investment in sugar-based energy and chemical projects.

To contact the reporter on this story: Justin Doom in New York at jdoom1@bloomberg.net

To contact the editor responsible for this story: Reed Landberg at landberg@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.